Two huge high school boys' basketball games took place Saturday, providing some awesome highlights from some of the best players in the San Antonio area.
15 children honored with ‘Dream Leader’ awards during San Antonio’s DreamWeek summitWoman arrested, faces animal cruelty charge after video shows her hitting puppy, ACS saysSuspect arrested in connection with crash that killed woman, injured two others, affidavit says
Read full article: Suspect arrested in connection with crash that killed woman, injured two others, affidavit saysSA Live deals this week: $5 off SA Coffee Festival & more– Two huge high school boys' basketball games took place Saturday, providing some awesome highlights from some of the best players in the San Antonio area.
The first matchup was a top-25 showdown in District 28-6A between the Brennan Bears and the Harlan Hawks at Northside Sports Gym.. The Bears got out to a quick lead and are up 56-34 at halftime. You’ll see the highlights tonight onBrennan’s ability to capitalize on turnovers led to a bunch of fast-break points, which led the Bears to a 56-34 lead at halftime.Then, over at Littleton Gym, there was a District 27-6A clash.
Here's how to get fabulous items to make life around the house easier, more organized and tidy — all while saving big.
High School Basketball Brennan Bears Harlan Hawks Johnson Jaguars Clark Cougars
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Aaron Taylor-Johnson and Sam Taylor-Johnson Celebrate End of 2024 with Romantic GetawayAaron Taylor-Johnson and his wife Sam Taylor-Johnson shared photos of their romantic vacation, showcasing intimate moments and breathtaking scenery. Aaron also shared shirtless photos, highlighting his physique.
Read more »
Johnson & Johnson's Lung Cancer Drugs Show Longer Survival Than AstraZeneca's TagrissoA clinical trial shows J&J's combination therapy extending survival for at least a year longer than Tagrisso. This breakthrough could change the treatment landscape for non-small cell lung cancer with EGFR mutations.
Read more »
Johnson & Johnson's Lung Cancer Drug Combo Shows Longer SurvivalJohnson & Johnson (J&J) announced that a combination of its lung cancer drugs, Rybrevant and Lazcluze, extended survival by at least a year compared to AstraZeneca's Tagrisso in a clinical trial. J&J aims to challenge Tagrisso's dominance as a leading treatment for non-small cell lung cancer with EGFR mutations.
Read more »
Johnson & Johnson Stock Hits Four-Year Low Amidst Rate Cut DoubtsJohnson & Johnson (JNJ) stock dropped to its lowest point in over four years on Wednesday, coinciding with a broader market decline fueled by expectations that the Federal Reserve may pause interest rate cuts due to a robust US labor market. Recent economic data, including strong job market indicators and an expanding services sector, have led investors to anticipate the Fed maintaining current interest rates. This development comes as JNJ received Fast Track status from the FDA for its Alzheimer's drug, posdinemab.
Read more »
Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 BillionJohnson & Johnson unveils a major acquisition, purchasing Intra-Cellular Therapies for $14.6 billion to bolster its central nervous system disorder treatment portfolio. The deal focuses on Caplyta, a promising drug for schizophrenia and depression, with strong anticipated growth.
Read more »
Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6 BillionJohnson & Johnson (J&J) is acquiring Intra-Cellular Therapies for over $14 billion, marking a significant investment in the treatment of central nervous system disorders. The deal includes a premium payment of $132 per share for Intra-Cellular, granting J&J ownership of Caplyta, a promising drug for schizophrenia and bipolar depression. J&J intends to leverage Intra-Cellular's pipeline, which includes potential treatments for anxiety, psychosis, and Alzheimer's-related agitation, to bolster its presence in this growing market.
Read more »